| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Gilles Paradis | Q61605194 |
| April L. Colosimo | Q37379093 | ||
| Arnaud Chiolero | Q54128535 | ||
| P2093 | author name string | Bernard Burnand | |
| Valérie Santschi | |||
| P2860 | cites work | Outcomes of pharmacist-managed diabetes care services in a community health center | Q79288755 |
| Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study | Q82263751 | ||
| Evaluation of a hypertension medication therapy management program in patients with diabetes | Q83481709 | ||
| Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial | Q95381061 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 | ||
| Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies | Q24608301 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers | Q28192645 | ||
| A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes | Q28218457 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension | Q30446418 | ||
| Smoking amplifies cardiovascular risk in patients with hypertension and diabetes | Q33610650 | ||
| A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study | Q33743492 | ||
| Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials | Q34215722 | ||
| Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial | Q34422037 | ||
| Consequences of smoking for body weight, body fat distribution, and insulin resistance | Q34768936 | ||
| Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes | Q35634210 | ||
| Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus | Q35657253 | ||
| Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management | Q36915765 | ||
| Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review | Q37117862 | ||
| Pharmacist care of patients with heart failure: a systematic review of randomized trials | Q37138834 | ||
| Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus | Q37201693 | ||
| Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. | Q37461889 | ||
| Benefits of moderate weight loss in patients with type 2 diabetes | Q37691477 | ||
| US pharmacists' effect as team members on patient care: systematic review and meta-analyses | Q37780942 | ||
| Effect of pharmacist intervention on glycemic control in diabetes | Q37801704 | ||
| Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review | Q37874052 | ||
| A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). | Q38385417 | ||
| A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). | Q43999899 | ||
| A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes | Q44994370 | ||
| Diabetes Ten City Challenge: final economic and clinical results | Q45324282 | ||
| Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. | Q46406392 | ||
| Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes | Q46442634 | ||
| Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial | Q46501552 | ||
| Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey | Q46966712 | ||
| Pharmacist-led group medical appointment model in type 2 diabetes. | Q48311456 | ||
| A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. | Q51496005 | ||
| A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. | Q51522593 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 2706-2717 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials | |
| P478 | volume | 35 |
| Q37343626 | A cluster-randomized controlled knowledge translation feasibility study in Alberta community pharmacies using the PARiHS framework: study protocol |
| Q43177166 | An introduction to the fundamentals of randomized controlled trials in pharmacy research |
| Q92136123 | Cardiovascular risk factor control in British adults with diabetes mellitus: Retrospective cohort study |
| Q38874628 | Clinical Pharmacist Team-Based Care in a Safety Net Medical Home: Facilitators and Barriers to Chronic Care Management |
| Q99405321 | Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review |
| Q101404760 | Compared benefits of educational programs dedicated to diabetic patients with or without community pharmacist involvement |
| Q38649661 | Current Controversies With Recent Cholesterol Treatment Guidelines. |
| Q58707367 | DREAMeR: Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review; study protocol of a randomised controlled trial |
| Q43106510 | Delivering on our potential: Pharmacists and diabetes care / Déployer notre potentiel : Les pharmaciens et le traitement du diabète |
| Q92313898 | Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress |
| Q90255694 | Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures |
| Q47921220 | Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components |
| Q64062635 | Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study) |
| Q50959575 | Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. |
| Q64076931 | Evaluation of the Effectiveness of Clinical Pharmacists' Consultation in the Treatment of Infectious Diseases: A Single-Arm, Prospective Cohort Study |
| Q39996858 | Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population |
| Q26743953 | Evidence-based pharmaceutical care: The next chapter in pharmacy practice |
| Q89240843 | Expansion of clinical pharmacist positions through sustainable funding |
| Q45301047 | Exploring the Quality of Systematic Reviews on Pharmacist Interventions in Patients With Diabetes: An Overview |
| Q37384476 | Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update |
| Q49234428 | Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update. |
| Q36390452 | Impact of Diabetes Care by Pharmacists as Part of Health Care Team in Ambulatory Settings: A Systematic Review and Meta-analysis |
| Q57070221 | Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost |
| Q88777754 | Impact of a pharmacist-physician collaborative care model on patient outcomes and health services utilization |
| Q89240846 | Impact of the clinical pharmacy specialist in telehealth primary care |
| Q34297241 | Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. |
| Q38638711 | Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of healthcare interventions in primary care and community settings. |
| Q50241717 | Intervention fidelity for a complex behaviour change intervention in community pharmacy addressing cardiovascular disease risk. |
| Q60311566 | Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study |
| Q93588030 | Letter to the editor |
| Q35194924 | Long-term effects of a diabetes boot cAMP on measures of diabetic care |
| Q28277142 | Meta-analyses: with confidence or prediction intervals? |
| Q49011495 | Pharmacist interventions for obesity: improving treatment adherence and patient outcomes |
| Q38369916 | Pharmacist-Driven Strategies for Hypertension Management in Los Angeles: A Community and Stakeholder Needs Assessment, 2014-2015. |
| Q50605166 | Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. |
| Q39310956 | Pharmacists need recognition as providers to enhance patient care |
| Q47765815 | Pharmacists' perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting |
| Q58119629 | Physician-community pharmacist collaborative care in diabetes management: a pilot study |
| Q57547417 | Quality indicators of pharmacists' services in community pharmacies in Paraná State, Brazil |
| Q37286417 | Real-world application of MedsCheck opportunities: The Costco pharmacists intervention trial for reduction of cardiovascular risk |
| Q36256416 | Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial. |
| Q34418636 | The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update |
| Q26786031 | The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update |
| Q40119227 | The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence |
| Q52644991 | The Professional Culture of Community Pharmacy and the Provision of MTM Services. |
| Q49385628 | The role of the pharmacist in the management of type 2 diabetes: current insights and future directions |
| Q48157865 | Train-the-trainer program on cardiovascular health for community pharmacists in Malaysia. |
Search more.